A previous report also examined the correlation of adiponectin and leptin concentrations with prostate cancer progression to CRPC and overall survival (OS) but reported that each alone did not contribute to the correlation, supporting the results of a previous report [47]. This evidence concerns the gene ADIPOQ and Familial prostate cancer.